Search results for "Vaccinations"


 
Results 71 - 80 of about 328 for "Vaccinations".
Sort by: Relevance | Newest | Oldest

New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised

One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022

When to test, isolate, prescribe for outpatient COVID-19

Panelists at ACP and Annals of Internal Medicine's eighth virtual forum on COVID-19 discussed the latest recommendations and treatment options.
https://immattersacp.org/archives/2022/03/when-to-test-isolate-prescribe-for-outpatient-covid-19.htm
1 Mar 2022

New ACIP Adult Immunization Schedule recommends changes to herpes zoster, pneumococcal, hepatitis B vaccines

The guidelines from the CDC's Advisory Committee on Immunization Practices (ACIP) also include information on COVID-19 vaccines, stressing that it is safe to co-administer them with other vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/2.htm
22 Feb 2022

New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions

A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022

New research on PASC, COVID-19 infection and vaccination during pregnancy

Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022

False positives on syphilis test after COVID-19 vaccination

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/02/false-positives-on-syphilis-test-after-covid-19-vaccination.htm
1 Feb 2022

New research on mixed vaccine boosters, long-term outcomes, omicron severity

A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022

New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis

The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022

Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk

Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022

News on booster doses and omicron, COVID-19 and women's health, outpatient treatments

Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next